FIRM FIXED PRICENO SET ASIDE USED.
XLCARE PHARMACEUTICALS INC - 3 LINE ITEMS FOR MONTELUKAST 10MG TABLET. AWARDED FOR A BASE YEAR OF 5/10/2026 TO 5/9/2027 PLUS 4 ONE-YEAR OPTION PERIODS.
PIID: 36E79726D0007Solicitation ID: 36E79725R0061
Signed Date: Jan 8, 2026Effective Date: May 10, 2026
Key Details
Description
3 LINE ITEMS FOR MONTELUKAST 10MG TABLET. AWARDED FOR A BASE YEAR OF 5/10/2026 TO 5/9/2027 PLUS 4 ONE-YEAR OPTION PERIODS.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.